{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:38:12Z","timestamp":1786991892562,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","award":["BE2022826"],"award-info":[{"award-number":["BE2022826"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jconrel.2026.114992","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:29:44Z","timestamp":1778340584000},"page":"114992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dual-adjuvanted GPC3 mRNA vaccine delivered by lipid nanoparticles for hepatocellular carcinoma immunotherapy"],"prefix":"10.1016","volume":"395","author":[{"given":"Yuhao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyaxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinsong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114992_bb0005","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000509424","article-title":"Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition)","volume":"9","author":"Zhou","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jconrel.2026.114992_bb0010","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.114992_bb0015","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2026.114992_bb0020","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/cac2.12591","article-title":"Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment","volume":"44","author":"Zhang","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jconrel.2026.114992_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-024-00539-x","article-title":"Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside","volume":"13","author":"Yin","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0030","series-title":"Annual Review of Immunology","first-page":"235","article-title":"Natural Innate and Adaptive Immunity to Cancer","volume":"29","author":"Vesely","year":"2011"},{"key":"10.1016\/j.jconrel.2026.114992_bb0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114992_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114992_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114992_bb0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.omtm.2023.01.006","article-title":"Tumor antigen-loaded AAV vaccine drives protective immunity in a melanoma animal model","volume":"28","author":"Krotova","year":"2023","journal-title":"Mol. Ther. Meth. Clin. Develop."},{"key":"10.1016\/j.jconrel.2026.114992_bb0055","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jconrel.2020.10.019","article-title":"Controlled release of immunotherapeutics for enhanced cancer immunotherapy after local delivery","volume":"329","author":"Jin","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114992_bb0060","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jconrel.2022.03.048","article-title":"Protein corona-driven nanovaccines improve antigen intracellular release and immunotherapy efficacy","volume":"345","author":"Du","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114992_bb0065","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/med.21455","article-title":"Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment","volume":"38","author":"Zhou","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2026.114992_bb0070","article-title":"Glypican-3: a novel and promising target for the treatment of hepatocellular carcinoma","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0075","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1016-8478(23)12884-6","article-title":"Cellular changes resulting from forced expression of glypican-3 in hepatocellular carcinoma cells","volume":"21","author":"Kwack","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2026.114992_bb0080","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.ymthe.2017.08.005","article-title":"A novel vaccine targeting glypican-3 as a treatment for hepatocellular carcinoma","volume":"25","author":"Wu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.114992_bb0085","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1158\/1078-0432.CCR-11-3044","article-title":"Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival","volume":"18","author":"Sawada","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114992_bb0090","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1158\/1078-0432.CCR-05-2267","article-title":"Identification of HLA-A2-or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma","volume":"12","author":"Komori","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114992_bb0095","article-title":"Peptide-based vaccine for cancer therapies","volume":"14","author":"Buonaguro","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2016.11.001","article-title":"Peptide vaccines in cancer - old concept revisited","volume":"45","author":"Kumai","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13025","article-title":"Peptide-based therapeutic cancer vaccine: current trends in clinical application","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.jconrel.2026.114992_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02141-5","article-title":"Advances and applications of RNA vaccines in tumor treatment","volume":"23","author":"Yang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114992_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/v16040544","article-title":"The mRNA vaccine expressing single and fused structural proteins of Porcine Reproductive and Respiratory Syndrome induces strong cellular and humoral immune responses in BALB\/c mice","volume":"16","author":"Zhou","year":"2024","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.jconrel.2026.114992_bb0120","doi-asserted-by":"crossref","first-page":"E450","DOI":"10.1016\/S1470-2045(22)00372-2","article-title":"Clinical advances and ongoing trials of mRNA vaccines for cancer treatment","volume":"23","author":"Lorentzen","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2025.08.2233","article-title":"Primary results from a randomized phase II trial of BNT111 in combination with cemiplimab with calibrator monotherapy arms in anti-PD-(L)1 relapsed\/refractory melanoma","volume":"36","author":"Ascierto","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114992_bb0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrclinonc.2014.111","article-title":"Therapeutic vaccines for cancer: an overview of clinical trials","volume":"11","author":"Melero","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","article-title":"Lipid nanoparticle technology for therapeutic gene regulation in the liver","volume":"159","author":"Witzigmann","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114992_bb0145","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114992_bb0150","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.mattod.2025.07.028","article-title":"Advances in the rational design of ionizable lipids for mRNA therapeutics","volume":"89","author":"Lee","year":"2025","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2026.114992_bb0155","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.mattod.2026.01.004","article-title":"Phospholipids tailor mRNA lipid nanoparticle delivery efficacy and immunogenicity","volume":"92","author":"Shi","year":"2026","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2026.114992_bb0160","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114992_bb0165","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent Cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114992_bb0170","article-title":"All-trans-retinoic acid-adjuvanted mRNA vaccine induces mucosal anti-tumor immune responses for treating colorectal cancer","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114992_bb0175","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.xphs.2022.12.026","article-title":"Effect of cholesterol content of lipid composition in mRNA-LNPs on the protein expression in the injected site and liver after local Administration in Mice","volume":"112","author":"Kawaguchi","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114992_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03681-8","article-title":"Spleen-targeted NeoPol-mL242 mRNA vaccine induces robust T-cell responses in a hepatocellular carcinoma model","volume":"23","author":"Wu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1646800","article-title":"Advances in molecular adjuvants for nucleic acid vaccines","volume":"16","author":"Hojecki","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21775\/cimb.022.017","article-title":"Molecular adjuvants for DNA vaccines","volume":"22","author":"Li","year":"2017","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0195","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/1521-4141(200105)31:5<1602::AID-IMMU1602>3.0.CO;2-W","article-title":"The role of heat shock protein (hsp70) in dendritic cell maturation:: Hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors","volume":"31","author":"Kuppner","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0200","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.4049\/jimmunol.169.5.2422","article-title":"Stimulation of Th1-polarizing maturation of dendritic cells, cytokines, C-C chemokines, and adjuvant function by the peptide binding fragment of heat shock protein 70","volume":"169","author":"Wang","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0205","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.febslet.2005.02.046","article-title":"Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial\/epithelial cells","volume":"579","author":"Th\u00e9riault","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2026.114992_bb0210","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.4049\/jimmunol.174.6.3306","article-title":"Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells","volume":"174","author":"Wang","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19261","article-title":"Immunoinformatics studies of heat shock proteins 27 and 70: development of potent therapeutic vaccine constructs against human papillomavirus-related cancers","volume":"9","author":"Rezaei","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2026.114992_bb0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5732\/cjc.011.10384","article-title":"Protective antitumor immunity induced by tumor cell lysates conjugated with diphtheria toxin and adjuvant epitope in mouse breast tumor models","volume":"31","author":"Wang","year":"2012","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.114992_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/biom14091161","article-title":"Research progress on dendritic cells in hepatocellular carcinoma immune microenvironments","volume":"14","author":"Li","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2026.114992_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01347-2","article-title":"Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA","volume":"9","author":"Li","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.114992_bb0235","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90201","article-title":"C3d regulates immune checkpoint blockade and enhances antitumor immunity","volume":"2","author":"Platt","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2026.114992_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-017-0623-0","article-title":"STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC","volume":"36","author":"Han","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114992_bb0245","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1080\/21645515.2016.1276140","article-title":"The revival of cancer vaccines - the eminent need to activate humoral immunity","volume":"13","author":"Huijbers","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2026.114992_bb0250","doi-asserted-by":"crossref","first-page":"21347","DOI":"10.1021\/jacs.5c07232","article-title":"Harnessing the Electron-withdrawing inductive effect of one-component ionizable amphiphilic Janus dendrimers unveils cation-\u03c0 interactions and their important roles to targeted mRNA delivery","volume":"147","author":"Arshad","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"34","key":"10.1016\/j.jconrel.2026.114992_bb0255","doi-asserted-by":"crossref","first-page":"18760","DOI":"10.1021\/jacs.3c07337","article-title":"Targeted and equally distributed delivery of mRNA to organs with pentaerythritol-based one-component ionizable amphiphilic Janus dendrimers","volume":"145","author":"Lu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114992_bb0260","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1021\/jacs.2c00273","article-title":"The unexpected importance of the primary structure of theHydrophobic part of one-component ionizable amphiphilic JanusDendrimers in targeted mRNA delivery activity","volume":"144","author":"Zhang","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114992_bb0265","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.1021\/jacs.1c05813","article-title":"One-component multifunctional sequence-defined ionizable amphiphilic Janus dendrimer delivery systems for mRNA","volume":"143","author":"Zhang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114992_bb0270","doi-asserted-by":"crossref","first-page":"17975","DOI":"10.1021\/jacs.1c09585","article-title":"Targeted delivery of mRNA with one-component ionizable amphiphilic Janus dendrimers","volume":"143","author":"Zhang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114992_bb0275","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2026.114992_bb0280","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114992_bb0285","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","article-title":"The complement system in regulation of adaptive immunity","volume":"5","author":"Carroll","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.114992_bb0290","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon Signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.114992_bb0295","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41573-022-00493-5","article-title":"Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities","volume":"21","author":"Kim","year":"2022","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:37:25Z","timestamp":1783161445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":59,"alternative-id":["S0168365926003950"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114992","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-adjuvanted GPC3 mRNA vaccine delivered by lipid nanoparticles for hepatocellular carcinoma immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114992"}}